A Study to Learn About the Long-Term Health of Adult Participants From a Previous Study of a New Melanoma Treatment
Clinical trial NCT06848088 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06848088
- Sponsor
- Regeneron Pharmaceuticals
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-14
- Primary completion
- 2029-10-10
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.